Big Pharma Still Hopeful For Next Mega Drugs To Supplement Sales
This article was originally published in The Pink Sheet Daily
Executive Summary
Drug makers need to continue investing in early-stage research to unveil the next $1 billion-plus drug, panelists at the Argyle conference agree.